Hunter Family Foundation Traumatic Brain Injury Translational Research Program
The University of Pittsburgh Hunter Family Foundation Traumatic Brain Injury Translational Research Program (the Hunter Program) was established to drive discoveries and technologies in the areas of nervous system injury, inflammation, and disease identified in the lab closer to products and treatments for patients. Made possible through the generosity of the Hunter Family, the program is designed to bridge the gap between academic bench science and commercial development by corporate partners or through the creation of new companies.
A single $100,000 award is granted each year to further develop Pitt technologies addressing unmet needs in the field of neuroscience with compelling proof-of-principle or proof-of-concept data.
The Hunter Program, administered by the Office of Innovation and Entrepreneurship (OIE), provides:
- Funding for key proof-of-concept or validation studies for technologies in the field of neuroscience and
- Innovation and commercialization education and training.
Funding is granted in the form of either:
- Proof-of-Concept and Prototype Funds to support key proof-of-concept studies, including in vivo experiments, hit-to-lead studies, prototype development, or benchtop testing or
- Precommercialization Project Funds to support key validation studies, including IND/IDE-enabling studies, pharm/tox studies, or developability assays.
Projects must be focused on advancing technologies towards commercialization and the use of innovations outside of the academic environment. Funding cannot be used for proof-of-principle or hypothesis-based research.